Circulating T regulatory cells migration and phenotype in glioblastoma patients: An in vitro study

Journal of Neuro-Oncology

Volumn 115, Issue 3, 2013, Pages 353-363

  Vasco, Chiara ^a   Canazza, Alessandra ^a   Rizzo, Ambra ^a   Mossa, Adele ^a   Corsini, Elena ^a   Silvani, Antonio ^a   Fariselli, Laura ^a   Salmaggi, Andrea ^b   Ciusani, Emilio ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

CCL2; Glioblastoma multiforme; Irradiation; Treg

Indexed keywords

CELL MARKER; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HELIOS PROTEIN; INTERLEUKIN 7 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE MIGRATION; MALE; REGULATORY T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84890254848     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1236-x     Document Type: Article

References (37)

1. Wainwright DA, Nigam P, Thaci B et al (2012) Recent developments on immunotherapy for brain cancer. Expert Opin Emerg Drugs 17(2):181-202
2. Behin A, Hoang-Xuan K, Carpentier AF et al (2003) Primary brain tumors in adults. Lancet 361:323-331
3. Curtin JF, Candolfi M, Fakhouri TM et al (2008) Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS ONE 3(4):e1983
4. Crane CA, Ahn BJ, Han SJ et al (2012) Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol 14(5):584-595
5. Fujimoto S, Greene MI, Sehon AH (1976) Regulation of the immuneresponse to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol 116:800-806
6. Ha TY, Park HJ, On KK et al (1995) Potentiation of anti-tumor immunity by modulation of suppressor T cells. II. Regression of tumor by modulation of suppressor T cells. Korean J Immunol 17:101-118
7. Ha TY (2009) The role of regulatory T cells in cancer. Immune Netw 9(6):209-235
8. + regulatory T cells. Int Immunopharmacol 11(10):1489-1496
9. Wang RF (2006) Regulatory T cells and innate immune regulation in tumor immunity. Springer Semin Imunopathol 28:17-23
10. + T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Human Immunol 70:477-486
11. Liu Z, Kim JH, Falo LD et al (2009) Tumor regulatory T cells potently abrogate antitimor immunity. J Immunol 182:6160-6167
12. + regulatory T cells in tumor infiltrating lymphocytes of human glioblastoma multiforme. Neuro Oncol 8:234-243
13. + regulatory T cells in human gliomas. Clin Cancer Res 14:5166-5172
14. Jacobs JF, Idema AJ, Bol KF et al (2010) Prognostic significance and mechanism of Treg infiltration in human brain tumors. J Neuroimmunol 225:195-199
15. Fecci PE, Mitchell DA, Whitesides JF et al (2006) Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res 66(6):3294-3302
16. Zhang J, Patel L, Pienta KJ (2010) Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog Mol Biol Transl Sci 95:31-53
17. Deshmane SL, Kremlev S, Amini S et al (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313-326
18. Del Pozo MA, Cabanas C, Montoya MC et al (1997) ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 137:493-508
19. Carrillo-de Sauvage MA, Gómez A, Ros CM (2012) CCL2-expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo. PLoS ONE 7:30762
20. Calatozzolo C, Canazza A, Pollo B et al (2011) Expression of the new CXCL12 receptor, CXCR7, in gliomas. Cancer Biol Ther 11(242-53):17
21. Conductier G, Blondeau N, Guyon A et al (2010) The role of monocyte chemoattractant protein CCL2/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224:93-100
22. Kim YH, Jung TY, Jung S et al (2012) Tumor-infiltrating T-cell subpopulations in glioblastomas. Br J Neurosurg 26:21-27
23. Donson AM, Birks DK, Schittone SA et al (2012) Increased immune gene expression and immune cell infiltration in high grade astrocytoma distinguish long-term from short-term survivors. J Immunol 189:1920-1927
24. Lowther DE, Hafler DA (2012) Regulatory T cells in the central nervous system. Immunol Rev 248(1):156-169
25. Jordan JT, Sun W, Hussain SF et al (2008) Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol Immunother 57(1):123-131
26. Parney IF, Waldron J, Parsa AT (2009) Flow citometry and in vitro analysis of human glioma associated macrophages. J Neurosurg 110(3):572-582
27. Lohr J, Ratliff T, Huppertz A et al (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res 17(13):4296-4308
28. de Chaisemartin L, Goc J, Damotte D et al (2011) Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 71(20):6391-6399
29. Wei S, Kryczek I, Zou W (2006) Regulatory T-cell compartmentalization and trafficking. Blood 108(2):426-431
30. Ménétrier-Caux C, Faget J, Biota C, Gobert M, Blay JY, Caux C (2012) Innate immune recognition of breast tumor cells mediates CCL2 secretion favoring Treg recruitment within tumorenvironment. Oncoimmunology 1(5):759-761
31. Weller M (2012) More on the immune privilege of glioblastoma. Neuro Oncol 14(5):527-528
32. Nalla AK, Gogineni VR, Gupta R et al (2011) Suppression of uPA and uPAR blocks radiation-induced CCL2 mediated recruitment of endothelial cells in meningioma. Cell Signal 23(8):1299-1310
33. Yan M, Jene N, Byrne D et al (2011) Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers. Breast Cancer Res 13(2):R47
34. Wainwright DA, Balyasnikova IV, Chang AL et al (2012) IDO Expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res 18(22):6110-6121
35. Coe D, Begom S, Addey C et al (2010) Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol Immunother 59:1367-1377
36. Cohen AD, Schaer DA, Liu C et al (2010) Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PLoS ONE 5:e10436
37. + T cells. Cancer Res 72:6130-6141